The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells by unknown
The Effect of Recombinant Mast Cell Growth Factor
on Purified Murine Hematopoietic Stem Cells
By Peter de Vries,* Kenneth A . Brasel,* June R . Eisenman,*
Alan R . Alpert,$ and Douglas E . Williams*
From the "Departments ofExperimental Hematology and
#Biochemistry, Immunex Corporation, Seattle, Washington 98101
Summary
Pluripotent hematopoietic stem cells (PHSC) are very rare cells whose functional capabilities
can only be analyzed indirectly . For abetter understanding and possible manipulation ofmechanisms
that regulate self-renewal and commitment to differentiation ofPHSC, it is necessary to purify
these cells and to develop assays for their growth in vitro. In the present study, a rapid and simple,
widely applicable procedure to highly purify day 14 spleen colony-forming cells (day 14 CFU-S)
is described . Low density bone marrow cells (p 41.078 g/cm3) were enriched by two successive
light-activated cell sorting procedures. In the first sort, cells within a predetermined light scatter
(blast cell) window that are wheat germ agglutinin/Texas Red (WGA/TxR) positive and mAb
15-1.4.1/fluorescein isothiocyanate negative (granulocyte-monocyte marker) were selected. In the
second sort, cells were selected on the basis of retention of the supravital dye rhodamine 123
(Rh123) . Cells that take up little Rh123 (Rh123 dull cells) and those that take up more Rh123
(Rh123 bright cells) were 237-fold and 132-fold enriched, respectively, for day 14 CFU-S.
Both Rh123 fractions were cultured for various time periods in vitro in the presence of mast
cell growth factor (MGF), with or without interleukin 3 (IIr3) or IIrlci. Both Rh123 fractions
proliferated in response to MGF alone as determined by a [3H]TdR assay or by counting
nucleated cells present in the cultures over time. MGF also acted synergistically with both 11,3
and Ilrltx to promote stem cell proliferation . Stimulation of both Rh123 fractions with MGF
alone did not result in a net increase of day 14 CFU-S. Stimulation with MGF + IL3 orMGF
+ II ot resulted in a 4.4- or 2.6-fold increase of day 14 CFU-S in the Rh123 dull fraction, and
an 11.6-fold or 2.6-fold increase of day 14 CFU-S in the Rh123 bright fraction, respectively .
The data presented in this paper indicate that in vitro MGF acts on primitive hematopoietic
stem cells by itself and also is a potent synergistic factor in combination with ID3 or IIlot .
H
ematopoiesis is a dynamic process by which large
numbers ofmature blood cells with very specific func-
tions and limited life spans are generated (reviewed in refer-
ence 1) . All the different blood cell types originate from a
common population ofpluripotent hematopoietic stem cells
(PHSC)t found predominantly in the bone marrow (BM) of
mammals. PHSC are normally quiescent and are character-
ized by their capacity to renew themselves and to generate
committed progenitors of the erythroid, megakaryocytic, my-
eloid, or lymphoid lineages (1, 2) .
A number ofprocedures based on physiochemical and im-
1 Abbreviations used in this paper. BM, bone marrow; CFU-S, spleen colony-
forming cells ; FLS, forward light scatter; HGF, hematopoieticgrowthfactor;
LD, low density; MGF, mast cell growth factor ; PHSC, pluripotent
hematopoietic stem cells; Rh 123, rhodamine 123 ; Sl, Steel locus ; SSC,
side light scatter ; TXR, Texas Red; W, white spotting; WGA, wheat germ
agglutinin .
munochemical characteristics have been developed for the
purification ofmurinePHSC (3-11) . The late spleen colony-
forming cells (day 12-14 CFU-S) have long been regarded
as thePHSC (12-14) and the purification ofday 12-14CFU-S
has often been used as an end point in many of the above
purification procedures . However, it has been noted that the
day 12-14 CFU-S content ofaBM graft does not adequately
predict the long term hematopoietic reconstitutive capacity
(the ultimate test for PHSC) of the graft (11, 15-17) . The
use ofthe mitochondrial dye rhodamine 123 (Rh123) revealed
a functional heterogeneity among day 12-14 CFU-S and has
attributed to the notion that only a subpopulation of day
12-14CFU-S is closely related to ifnot identical withPHSC
(7, 9-11, 18, 19) .
In vitro analysis of the growth and proliferation require-
ments ofpurified stem cell fractions may well lead to a better
understanding ofthe factors involved in the regulation of self-
renewal and differentiation . Multiplication of purified stem
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tially for gene therapy. Thus far, attempts to culture (purified)
day-12 CFU-S in vitro have not resulted in the net in vitro
production of these cells (20, 21) .
Recently a new hematopoietic growth factor (HGF) has
been described called mast cell growth factor (MGF), stem
cell growth factor, or kit ligand (22-24) . The gene encoding
this factor maps to the Steel (Sl) locus of themouse (24, 25)
and is the ligand for the c-kit proto-oncogene, the product
of the dominant white spotting (W) locus (26) . It has long
been appreciated that mutations at the Sl andW loci cause
a severe impairment of PHSC development. The defect in
W is intrinsic to thehematopoietic stem cells themselves (27,
28) while that in Sl is in the stromal microenvironment (27,
29, 30) . Considering the seriousness of these defects it is of
interest to study the effect ofMGF on normal hematopoietic
stem cells.
In thepresentstudywe describe a relatively rapidandsimple
procedure to purify hematopoietic stem cells (day-14CFU-S) .
This procedure was used to examine the effect ofrMGF ei-
ther aloneor in combination with other HGFs on theprolifer-
ation and growth ofpurified stem cell fractionsin vitro. We
demonstrate that MGF in combination with IIr3 or ILia
in suspension cultures causes a net production of day-14
CFU-S.
Materials and Methods
Mice. Throughout this study 6- to 8-wk-old female B6C3
(C57B1/6 x C3H/HeN)F, mice (Charles River Breeding Labora-
tories, Wilmington,MA)were used asBM donors or asBM trans-
plantation recipients in the CFU-S assay. The mice were housed
in conventional animal quarters .
Preparation of Cell Suspensions.
￿
BM cell suspensions were ob-
tained by flushing the femoraland tibial shafts with 1 ml ice cold
Hepes buffered (10mM, pH 6.9) HBSS without phenol red (HH;
Gibco Laboratories, Grand Island, NY) . After repeated pipetting,
the cells were passed througha88,umpore size Nitex filter (Small
Parts Inc., Miami, Florida), washed andcounted in a hemocytom-
eter. Cells were kept on ice unless stated otherwise.
Spleen Colony Forming Assay(CFU-S Assay).
￿
To determine the
CFU-Scontent ofBM cell suspensions, the spleen colony forming
assaywas used (12) . Unfractionated and sortedBM cells were trans-
planted intravenously (lateral tail vein) into lethally irradiated
recipients (7-10 per group) . The mice were exposed to 950 rad
of gamma irradiation from a '3'Cs source (Mark 1 irradiator ;
Shepard and Associates, Glendale, CA) at a dose rate of 245 rad
per min, and were transplanted 1-4 h after irradiation .
14d after transplantation themice were killed and their spleens
were removedand fixed in Teleyesniczki's solution. Themacroscop-
ically visible spleen colonies (day 14 CFU-S) were counted.
Immunofluorescence StainingforStem Cell Purification.
￿
BM cells
were separatedon a discontinuous density gradient ofmetrizamide
(Nycomed, Oslo,Norway) as previously described (3) . During the
centrifugation (1,000g, 10 min, 15°C)the cellswere stained with
Texas Red conjugated wheat germ agglutinin (WGA/TxR : 1
Rg/ml; Molecular Probes Inc., Eugene, OR) . Thelow density (LD)
cells (p 4 1.078 g/cm3) were collected, washed once in HH,
resuspended in HH containing 5% heat-inactivated FCS (Reha-
tuin, Purchase, NY)and0.2%sodium azide (HSA ; HH + Serum
+ Azide) and stained with FITC conjugated mAb 15-1.4 .1 (15-
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1.4.1/FITC) . mAb 15-1.4.1 is directed against mature murineBM
monocytes and granulocytes and their immediate precursors, but
does not react with day 14 CFU-S (31) . After 30 min on ice the
cells were washedonce with HSA . The cells were resuspended in
HH + 5% FBS (HS : HH + Serum) at a concentration of 2-4
x 106 cells/ml and analyzed and sorted .
Sorted cells were subsequently stained with Rh123 (Eastman
KodakCo., Rochester,NY)and at the same timeWGA/TxRwas
removed from the cells by incubating the cells at 37°C for 20 min
in 0.2MN-acetyl-D-glucosamine + 5%FBSand 0.1,ug/ml Rh123
(9) . Aftertwo washes with HH the cells were resuspended in HS,
analyzed and resorted.
Light Activated Cell Sorting.
￿
Stained cells were analyzed and
sortedwith an unmodified duallaser equipped FACStar® Plus flow
cytometer (Becton-Dickinson and Co ., San Jose, CA) in the fol-
lowing way : first, the WGA/TxR positive cells were selected by
setting electronic gates around these cells using theFACStar® soft-
warepackage(BectonDickinsonandCo.) . Second, the "blast cells"
were selected by gating out theWGA positive (WGA+) cells with
intermediate to high forward light scatter (FLS) andlow to inter-
mediate side light scatter(SSC) intensities (3). Finally, the 15-1.4 .1
negative WGA+ blast cells were selected . The selected WGA' /
15-1.4.1- LD blast cells were sorted (normal-R mode). During
the sort the cells were kept at 4°C .
After removal ofWGA/TxRconjugates and staining with Rh123
(see above) the cells were run through the sorter again . Cells in
the same FCS/SSC window as during the first sort were sorted
on basis of their Rh123 fluorescence intensity into a Rh123 dull
and Rh123 bright population .
The first laserwas operated at 488 nm and 200mW andgener-
ated FLS, SSC, FITC,andRh123 signals . The FLS signal was used
to trigger the electronics of the system . FLS andSSCwere amplified
linearly. FITC and Rh123 signals were measured through a DF
530/30 filter andwere amplified logarithmically. TxRfluorescence
was generated by the second laser operating in all lines mode at
2W and used to pump a dye laser filled with Rhodamine 6G to
generate light of 590 nm and 75mW TxR signals were measured
through a DF 630/22 filter and amplified logarithmically.
Liquid Cultures.
￿
Sorted Rh123 dull andRh123 bright stem cells
were seeded into 24-well tissue culture plates (Costar, Cambridge,
MA) and cultured in the presence or absence of HGF(s) at a final
volume of2 ml/well . Cells were cultured in McCoy's 5A medium
(Gibco Laboratories) supplemented with 20% heat inactivated FBS,
50 1AM 2-ME, essential + nonessential amino acids, sodium-
pyruvate, vitamins, glutamine, penicillin, and streptomycin . Cells
were incubated at 37°C in a fully humidified atmosphere of 6.5%
COz and 7% OZ in air. After the indicated number of days the
cells were harvested, washed once withHH,counted (trypan blue),
and injected into lethally irradiated recipients for determination of
the day 14 CFU-S content.
Proliferation Assays .
￿
Proliferation of purified stem cells was as-
sessed in [3H]TdR incorporation assays. Cells were cultured in sup-
plemented McCoy's 5A medium in the presence or absence of
HGF(s) in 96-well flat-bottom tissue culture plates (Costar) at a
final volume of 200 Al/well . Cells were incubated at 37°C in a
fully humidified atmosphere of 6.5% COz and 7% OZ in air for
96 h . Subsequently, the cells were pulsed with 2 14Ci per well of
[3H]TdR (81 Ci/mmol; Amersham Corp., Arlington Heights, IL)
andincubated for an additional 16 h . Samples were harvestedonto
glass fiber filters and counted using Geiger-Muller gas ionization
(Packard Matrix 96 counter ; Packard Instrument Company,
Meriden, CT).
Hematopoietic Growth Factors.
￿
Murine rI1r3 andhumanrILlcx
were used at a final concentration of 250 ng/ml. Murine rMGF
On Purified Murine Stem Cellswas used at a concentration of285 ng/ml, unless stated otherwise.
Murine rMGF was purified from yeast supernatant as described
(32) . All hematopoietic growth factors were manufactured by Im-
munex Corp. (Seattle, WA).
Statistical Analysis.
￿
The SD of the CFU-S counts were calcu-
lated using Poisson distribution statistics . Production of day 14
CFU-S in suspension cultures was tested for statistical significance
using the Wilcoxon rank-sum test .
Results
Purification o,fHematopoietic Stem Cells.
￿
Anew purification
procedure for the enrichment of day 14 CFU-S was devel-
oped that is relatively fast and simple and consists of a den-
sity cut followed by two cell sorting runs . In the first sort
the cells were selected on the basis of their light scatter char-
acteristics (FLS and SSC), WGA/TxR, and mAb 15-
1.4.1/FITC-fluorescence intensities (Fig . 1, A-C) . In the
second sort the cells were selected on the basis of their Rh123
fluorescence intensity (Fig. 1, D). With this purification pro-
cedure high enrichments of day 14 CFU-S could be obtained
(Table 1) . The Rh123 dull/WGA+ /15-1.4 .1 - /LD blast cells
(Rh123 dull cells) were on average, 237-fold enriched for day
14 CFU-S, 1.8 times more enriched than the Rh123 bright
WGA'/15-1.4.1- /LD blast cells (Rhi23 bright cells) . Rh123
bright cells are generally considered to be less primitive than
the Rh123 dull cells (7-11, 18, 19) . In the present study we
did not determine the long term reconstitutive capacity and
marrow and thymus repopulating ability of the sorted Rh
123 fractions . Previously the Rh 123 dull fraction, enriched
similarly for day 12-14 CFU-S using a number of different
purification protocols, has been shown to contain stem cells
Figure 1.
￿
Flow cytometric selection ofhemopoietic stem cells. (A) se-
lection of WGA/TxR* cells. (B) selection of "blast" cells on the basis
of FLS and SSC intensities. (C) selection of 15-1 .4.1/FITC- cells. (D)
Rh123 fluorescence distribution ofthe cells selected in steps (A) (B), and
(C) . The dot plots show only nucleated low density mouseBM cells. A
FLS threshold was set to electronically gate out erythrocytes .
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Table 1 .
￿
Frequency and Enrichment of Day 14 CFU-S in
Sorted Cell Populations
Enrichment
factor
bone marrow
￿
100.00
￿
35.4 ± 3 .1
￿
1
Rh123 dull cells
￿
0.03
￿
8,400 ± 864
￿
237
Rh123 bright
cells
￿
0.03
￿
4,666 ± 950
￿
132
The figures represent the mean ± SD of 15 experiments in which 150
sorted 111123 dull and 150 Rh123 bright cells or 2.5-3 x 104 unsepa-
rated nucleatedBM cells were injected into groups of 10 lethally irradi-
ated syngeneic recipients .
with long term reconstituting capacity and marrow and
thymus repopulating ability, whereas the Rh123 bright frac-
tion predominantly consisted of more mature in vivo and
in vitro clonogenic stem cells (7-11, 18, 19, P . de Vries, un-
published data) .
MGFStimulates the Proliferation ofPurified Stem Cell Frac-
tions. We studied the effect ofMGF on the purified stem
cell suspensions in a [3H]TdR assay . The results of studies
in which Rh123 dull and Rh123 bright fractions were cul-
tured in the presence ofdifferent concentrations ofMGF are
depicted in Fig. 2 . It is apparent that both the Rh123 dull
and Rh123 bright stem cells proliferated in the presence of
MGF alone. The Rh123 bright stem cells were more respon-
sive to MGF than the Rh123 dull stem cells . The dose re-
sponse curves indicated that maximal proliferation ofRh123
bright and Rh123 dull stem cellswas obtained with the same
concentration ofMGF. However, the 3H-cpm maximum of
Rh123 bright cells was almost four times higher than that
of Rh123 dull cells (Fig. 2) .
2000
1600
1200
CL
U 800
400
Rh123 bright
Rh123 dull
0 200 400 600 800 1000 1200
CONCENTRATION rMGF ft/ml)
Figure 2 .
￿
rMGF stimulates the proliferation of purified stem cell frac-
tions in a dose dependent way. Cell input at the initiation of the experi-
ment: 705 110123 dull and 728 Rh123 bright cells per well. Each point
represents the mean number of cpm from four wells ± SD .
Percent of
nucleated BM Day 14 CFU-S
Cell suspension cells per 101 cells
UnseparatedMGF Acts Synergistically with IL3 and IL1a.
￿
We showed
that MGF alone could stimulate the proliferation of purified
stem cell suspensions. We were interested to see if such stim-
ulation by MGF could be enhanced by the addition of other
HGFs . We therefore compared the [3H]TdR incorporation
ofpurified stem cell fractions when cultured withMGF, IL3,
or I1rla either alone or in combination .
Rh123 bright cells were more responsive than Rhl23 dull
cells when stimulated with any of the factors alone, particu-
larly in the case of IL3 stimulation (Table 2) . The prolifera-
tion induced by MGF alone in both cell fractions was less
than that induced by 11,3 alone . MGF and IL3 in combina-
tion resulted in a greater than additive [ 3H]TdR incorpora-
tion compared with cultures with either factor alone. By com-
paring the expected cpm for MGF and IL3 alone with that
obtained for the combination, the synergistic effect ofMGF
and IL3 in theRh123 dull fraction was about five times greater
than in the Rh123 bright fraction (Table 2) . Similarly, MGF
andIlls also acted synergistically on bothRh123 fractions .
The synergistic effect ofMGF and ILla was approximately
two times greater on Rh123 dull stem cells than on Rh123
bright stem cells. The synergistic effect of MGF with IL3
and IL1a was identical for the Rh123 dull cells, whereas in
the Rh123 bright fraction the synergy between IL1a and
MGF was 2.5 times greater than between MGF and IL3 .
MGF Causes the Production ofNucleated Cells.
￿
Purified stem
cell fractions were cultured for various times in MGF, IL-3,
or 11-Act alone, or in MGF + IL3 or 11,1a . At the indicated
times (after 4, 7, 11, and 14 d) the cells were collected, counted
and injected into lethally irradiated syngeneic recipients to
determine the day 14 CFU-S content (see below) .
MGF alone significantly stimulated the proliferation of
Rh123 dull and Rh123 bright cells (Fig . 3) as was also ob-
served in the [3H]TdR assay. The production of viable cells
in the Rh123 bright fraction was higher than in the Rh123
dull fraction . This is in agreement with the [ 3H]TdR incor-
poration data and suggests that Rh123 bright cells may be
more sensitive to MGF alone than Rh123 dull cells .
Table 2 .
￿
rMGF Alone and in Combination with rIL-3 or IL-1a
Stimulates Proliferation ofPurred Stem Cell Fractions
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CULTURE CONDITIONS
4 days
p 7 days
® 11 days
O 14 days
Figure 3 .
￿
rMGF stimulates the production of nucleated BM cells in
liquid culture by purified stem cell fractions. (A) Rh123 dull cells; 1277
cells seeded per well at day 0 . (B) Rh123 bright cells; 1592 cells seeded
per well at day 0.
A synergistic effect on nucleated cell production was ob-
served between MGF + IL3 and MGF + IIr1a . The syner-
gistic effect was greater on Rh123 dull cells than on Rhl23
bright cells, in agreement with the results obtained with the
[3H]TdR assay (Table 2) . The production of nucleated cells
in cultures withMGF alone or with MGF plus IL3 or ILla
started after day 4 and reached amaximum after 11 d, except
in the Rh123 dull fraction cultured with MGF alone where
the number was highest after 14 d (Fig. 3) .
Production ofDay-14 CFU-S In Vitro .
￿
Cells from the same
cultures as described above were injected into lethally irradi-
ated syngeneic recipients to determine the day 14CFU-S con-
tent of these cultures and to find out if day 14 CFU-S were
produced during in vitro culture. Culture of sorted cells with
MGF alone over a 14-d culture period did not stimulate the
net production of day 14 CPU-S in vitro from either Rh123
dull of Rh123 bright stem cells . However, MGF alone
promoted the survival of day 14 CFU-S in vitro for up to
14 d (Fig. 4) .
Culture of sorted cells with DO alone did not stimulate
a statistically significant net production of day 14 CFU-S in
the Rh123 dull or Rh123 bright fraction . Culture of sorted
stem cells with MGF + IL3, did not result in net produc-
Growth stimulus
None
Rh123
15±2
dull
cpm
Rh123 bright
10±5
IL-1a 20 ± 5 31 ± 13
MGF 537 ± 139 1,384 ± 229
IL-3 1,917 ± 260 12,186 ± 1,736
MGF+IL-3 51,781 ± 8,722 53,151 ± 5,812
MGF+IL-la 13,104 ± 4,008 14,158 ± 2,024F
GL
Z
to
W
F-
v
tL U
r
Q
" 4 days
days
® 11 days
O 14 days
CULTURE CONDITIONS
Figure 4.
￿
Effect ofrMGF on day 14 CFU-S numbers in Rh123 dull
and bright fractions after several days in liquid culture. At the start of
the culture 116 Rh123 dull (A), and 83 Rh123 bright (B) day 14 CPU-S
were seeded per well . For determination ofday 14 CFU-S contents recip-
ient mice (7 to 10 per group) were injected with 5,000 cultured cells . The
number of day 14 CFU-S in the bars indicated by an asterisk (') were
significantly different from the input numbers of day 14 CFU-S at the
5% level using the Wilcoxon rank-sum test. nd ; not done.
tion of day 14 CFU-S in the Rh123 dull and bright fractions
4 d after the onset of the cultures. However, from day 4 on-
ward, day 14 CFU-S were produced in a synergistic fashion .
In the Rh123 dull fraction, a 4.4-fold maximum increase in
day 14 CFU-S was observed after 14 d in culture, however,
this production was not statistically significant. In theRh123
bright fraction, a larger and statistically significant produc-
tion (11.6-foldmaximum increase after 11 d) of day 14 CFU-S
was observed in cultures containing MGF and IL3 (Fig . 4) .
MGF and IL1a also acted synergistically in the produc-
tion of day 14CFU-S in both Rh123 fractions. The produc-
tion ofday 14CFU-S with this factor combination was first
observed after 11 d in culture, 4 d later than was observed
in cultures with MGF + IL3 indicating a heterogeneity in
the sorted cell suspensions . After 11 and 14 d of culture the
day 14 CFU-S numbers in MGF + IL1a containing cul-
tures in the Rh123 dull and Rh123 bright fraction were 2
to 2.5 times higher than the input numbers at the start of
the cultures (Fig. 4) . The increase in the number of day 14
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CFU-S in the Rh123 bright fraction after 11 d in culture
with MGF and IL1a was statistically significant, whereas
the production after 14 d and in the Rh123 dull fractions
appeared not to be statistically different from the number
of day 14 CFU-S at the start ofthe cultures . Thus, theRh123
bright cells appeared to be more responsive to MGF in com-
bination with IIr3 or IL1a than the Rh123 dull cells with
respect to their capacity to generate day 14 CFU-S, at least
during the 14-d period of these experiments. However, the
synergistic effect ofMGF in combination with 11,3 or II,1cf
was greater in the Rh123 dull fraction . It should be noted,
that in the Rh123 dull fraction, despite the fact that the in-
crease in day 14 CFU-S was not statistically significant, the
trend was continuing upward even at day 14 in culture. Thus,
longer term cultures may be needed to observe production
of day 14 CFU-S in theRh123 dull population . This would
be in keeping with the generally assumed more primitive na-
ture ofRh 123 dull day 14 CFU-S than the Rh 123 bright
day 14 CFU-S.
Discussion
in this report we demonstrate a net production of day 14
CFU-S grown in liquid cultures of purified hematopoietic
stem cells (day 14 CPU-S) . It can be seen from our data that
in order to achieve this production of day 14 CFU-S, at least
two HGFs were required which act in a synergistic fashion
(Fig . 4) . One of these factors was MGF, which is encoded
by the S1 locus on mouse chromosome 10 . Two other neces-
saryHGFs for production ofday 14CFU-S in vitro appeared
to be either IIr3 or ILloc It has been reported that IL -3 does
not act on cells in the Ga phase of the cell cycle, and there-
fore is not capable of acting directly on the most primitive
stem cells, which are normally quiescent cells (33-36) . ILlu
on its own has no direct stimulatory effects on the prolifera-
tion ofprimitive hematopoietic cells (37, 38, this paper), but
may promote responsiveness to other later acting hema-
topoietins .
MGF acted synergystically with IL3 and IL1a on the
proliferation and net production of day 14 CFU-S (Figs . 3
and 4, Table 2) . The effects ofMGF, certainly early after the
onset ofthe cultures, were most likely directly on the purified
stem cells themselves, because of the low numbers of cells
seeded into these cultures and because cells such as endothelial
cells, fibroblasts, macrophages, and T lymphocytes, known
to produce HGFs, were removed by the sorting procedure
(see Fig . 1) .
A 237-foldmean enrichment ofRh123 dull day 14 CFU-S
and an 132-fold enrichment for Rh123 bright day 14 CFU-S
was obtained with the purification procedure described here
(Table 1) . If the number of day 14 CFU-S in unseparated
BM is considered, the enrichment factors obtained are in good
agreement with previously published procedures (3-5, 7, 39) .
With the new separation procedure it is possible to purify
hematopoietic stem cells (day 14 CFU-S) without require-
ment for any fluorescent probes or magnetic-bead conjugated
antibodies bound to the cell surface . Using the technique de-
scribed in this report loss of stem cells due to opsonizationby cells in the reticuloendothelial system is avoided (40) . In
addition, thenew procedure is widely applicable and not re-
stricted to cells of mouse strains with certain specific haplo-
types (31), in contrast to other procedures which are either
MHC class-1 or Ly-6b haplotype restricted (3-5, 7) .
In this study we did not determine the spleen seeding
efficiency (41) of the sorted stem cell fractions neither before
nor after in vitro culture . Ifwe assume like others (3, 5) a
spleen seeding efficiency of 10% it can be calculated from
Table 1 that the Rh 123 dull fraction averaged 84% day 14
CFU-S and the Rh123 bright fraction 47% day 14 CFU-S.
It has been demonstrated before, but not in this study, that
at least a proportion of the Rh123 dull cells are capable of
reconstituting the complete hematopoietic system (myeloid
and lymphoid) of lethally irradiated recipients and are there-
fore considered to bePHSC (7, 10, 11, 15), whereas the Rh123
bright fraction consists predominantly of less primitive com-
mitted stem and progenitor cells. Ploemacher and Brons (11)
and others (7, 18) have proposed the existence ofa more primi-
tive stem cell than the day 12-14 CFU-S present in the Rh123
dull fraction . This cell (pre-CFU-S) does not form spleen
colonies within 2 wk after transplantation, but is considered
to be the precursor for day 14 CFU-S (16) . In the Rh123
dull fraction no statistically significant production ofday 14
CFU-S was observed with MGF + IL-3 or with MGF +
IL1cx, although an increased production of day 14 CFU-S
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